Rod vision is initiated when 11-cis-retinal, bound within rhodopsin, absorbs a photon and isomerizes to all-trans-retinal (ATR). This triggers an enzyme cascade that lowers cGMP, thereby closing cyclic nucleotide-gated (CNG) channels. ATR then dissociates from rhodopsin, with bright light releasing millimolar levels of ATR. We have recently shown that ATR is a potent closed-state inhibitor of the rod CNG channel, and that it requires access to the cytosolic face of the channel (McCabe, S.L., D.M. Pelosi, M. Tetreault, A. Miri, W. Nguitragool, P. Kovithvathanaphong, R. Mahajan, and A.L. Zimmerman. 2004. J. Gen. Physiol. 123:521–531). However, the details of the interaction between the channel and ATR have not been resolved. Here, we explore the nature of this interaction by taking advantage of specific retinoids and retinoid analogues, namely, β-ionone, all-trans-C15 aldehyde, all-trans-C17 aldehyde, all-trans-C22 aldehyde, all-trans-retinol, all-trans-retinoic acid, and all-trans-retinylidene-n-butylamine. These retinoids differ in polyene chain length, chemical functionality, and charge. Results obtained from patch clamp and NMR studies have allowed us to better define the characteristics of the site of retinoid–channel interaction. We propose that the cytoplasmic face of the channel contains a retinoid binding site. This binding site likely contains a hydrophobic region that allows the ionone ring and polyene tail to sit in an optimal position to promote interaction of the terminal functional group with residues ∼15 Å away from the ionone ring. Based on our functional data with retinoids possessing either a positive or a negative charge, we speculate that these amino acid residues may be polar and/or aromatic.
Skip Nav Destination
Article navigation
1 November 2005
Article Contents
Article|
October 17 2005
Defining the Retinoid Binding Site in the Rod Cyclic Nucleotide-gated Channel
Diana M. Horrigan,
Diana M. Horrigan
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Search for other works by this author on:
Michelle L. Tetreault,
Michelle L. Tetreault
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Search for other works by this author on:
Natia Tsomaia,
Natia Tsomaia
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Search for other works by this author on:
Chrysoula Vasileiou,
Chrysoula Vasileiou
2Department of Chemistry, Michigan State University, East Lansing, MI 48824
Search for other works by this author on:
Babak Borhan,
Babak Borhan
2Department of Chemistry, Michigan State University, East Lansing, MI 48824
Search for other works by this author on:
Dale F. Mierke,
Dale F. Mierke
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Search for other works by this author on:
Rosalie K. Crouch,
Rosalie K. Crouch
3Department of Ophthalmology, Medical University of South Carolina, Charleston, SC 29425
Search for other works by this author on:
Anita L. Zimmerman
Anita L. Zimmerman
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Search for other works by this author on:
Diana M. Horrigan
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Michelle L. Tetreault
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Natia Tsomaia
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Chrysoula Vasileiou
2Department of Chemistry, Michigan State University, East Lansing, MI 48824
Babak Borhan
2Department of Chemistry, Michigan State University, East Lansing, MI 48824
Dale F. Mierke
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Rosalie K. Crouch
3Department of Ophthalmology, Medical University of South Carolina, Charleston, SC 29425
Anita L. Zimmerman
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Providence, RI 02912
Correspondence to Anita L. Zimmerman: [email protected]
Abbreviations used in this paper: ATR, all-trans-retinal; ATR-NBu, all-trans-retinylidene-n-butylamine; ATRol, all-trans-retinol; CNG, cyclic nucleotide-gated; DPC, dodecylphosphocholine; NMR, nuclear magnetic resonance.
Received:
August 16 2005
Accepted:
September 16 2005
Online ISSN: 1540-7748
Print ISSN: 0022-1295
The Rockefeller University Press
2005
J Gen Physiol (2005) 126 (5): 453–460.
Article history
Received:
August 16 2005
Accepted:
September 16 2005
Citation
Diana M. Horrigan, Michelle L. Tetreault, Natia Tsomaia, Chrysoula Vasileiou, Babak Borhan, Dale F. Mierke, Rosalie K. Crouch, Anita L. Zimmerman; Defining the Retinoid Binding Site in the Rod Cyclic Nucleotide-gated Channel . J Gen Physiol 1 November 2005; 126 (5): 453–460. doi: https://doi.org/10.1085/jgp.200509387
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Occupancy of the Chromophore Binding Site of Opsin Activates Visual Transduction in Rod Photoreceptors
J Gen Physiol (March,1999)
Bleached pigment activates transduction in salamander cones.
J Gen Physiol (September,1995)
Cyclic Nucleotide-gated Ion Channels in Rod Photoreceptors Are Protected from Retinoid Inhibition
J Gen Physiol (September,2006)
Email alerts
Advertisement